Sponsor Dossier
Reckitt Benckiser
Sponsor Dossier for Reckitt Benckiser. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: BONJELA
- Brand: CARDIPRIN
- Brand: CLEARASIL
- Brand: Copy
- Brand: DETTOL ANTISEPTIC
- Brand: DISPRIN
- Brand: Fybogel
- Brand: GAVISCON
- Device (sponsor): Teething gel
- Device (sponsor): Sexual lubricant
- Device (sponsor): Basic male condom, synthetic polymer
- Device (sponsor): Sexual lubricant
- Device (sponsor): Basic male condom, Hevea-latex
- Device (sponsor): Basic male condom, synthetic polymer
- Device (sponsor): General-body orifice lubricant, sterile
About
Reckitt Benckiser is an Australian Private Company with ABN 17003274655, registered in NSW and currently active.
Portfolio
Reckitt Benckiser has 18 brands on the ARTG, of which 5 are indexable and 2 carry a Product Information document. 3 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include BONJELA, CARDIPRIN, CLEARASIL, Copy, DETTOL ANTISEPTIC, DISPRIN, Fybogel, GAVISCON, GUARDIUM, Lemsip, NUROFEN, NUROMOL DUAL ACTION PAIN.
Therapeutic focus
— Pain Management: 6 brands — Gastroenterology: 5 brands — Dermatology: 3 brands — Respiratory: 2 brands — Ophthalmology: 1 brand — Cardiology: 1 brand
PBS footprint
3 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2014-11-01, across 0 brands with a PBAC outcome on record.